The reversed binding of β-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors

The co-crystal structure of β-phenethylamine fragment inhibitor 5 bound to DPP-IV revealed that the phenyl ring occupied the proline pocket of the enzyme. This finding provided the basis for a general hypothesis of a reverse binding mode for β-phenethylamine-based DPP-IV inhibitors, allowing novel i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2006-03, Vol.16 (6), p.1744-1748
Hauptverfasser: Nordhoff, Sonja, Cerezo-Gálvez, Silvia, Feurer, Achim, Hill, Oliver, Matassa, Victor G., Metz, Günther, Rummey, Christian, Thiemann, Meinolf, Edwards, Paul J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The co-crystal structure of β-phenethylamine fragment inhibitor 5 bound to DPP-IV revealed that the phenyl ring occupied the proline pocket of the enzyme. This finding provided the basis for a general hypothesis of a reverse binding mode for β-phenethylamine-based DPP-IV inhibitors, allowing novel inhibitor design concepts that obviate substrate-like structure–activity relationships (SAR). The co-crystal structure of β-phenethylamine fragment inhibitor 5 bound to DPP-IV revealed that the phenyl ring occupied the proline pocket of the enzyme. This finding provided the basis for a general hypothesis of a reverse binding mode for β-phenethylamine-based DPP-IV inhibitors. Novel inhibitor design concepts that obviate substrate-like structure–activity relationships (SAR) were thereby enabled, and novel, potent inhibitors were discovered.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2005.11.103